Aspen, GlaxoSmithKline deal

Aspen granted GSK an option to license rights to commercialize an undisclosed number of Aspen’s branded generics in emerging markets outside of sub-Saharan Africa. Aspen will receive upfront payments for additional regulatory work in countries where the products are not yet approved and is eligible for undisclosed royalties. Further terms were not disclosed. ...